137 related articles for article (PubMed ID: 35727596)
1. Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy.
Liu LB; Huang SH; Qiu HL; Cen XF; Guo YY; Li D; Ma YL; Xu M; Tang QZ
Br J Pharmacol; 2022 Sep; 179(18):4516-4533. PubMed ID: 35727596
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy.
Zhang DH; Zhang JL; Huang Z; Wu LM; Wang ZM; Li YP; Tian XY; Kong LY; Yao R; Zhang YZ
J Am Heart Assoc; 2020 Nov; 9(22):e017751. PubMed ID: 33170082
[TBL] [Abstract][Full Text] [Related]
3. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300.
Shen P; Feng X; Zhang X; Huang X; Liu S; Lu X; Li J; You J; Lu J; Li Z; Ye J; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):31-40. PubMed ID: 27094368
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
[TBL] [Abstract][Full Text] [Related]
5. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy.
Lu J; Sun D; Liu Z; Li M; Hong H; Liu C; Gao S; Li H; Cai Y; Chen S; Li Z; Ye J; Liu P
Transl Res; 2016 Jun; 172():96-112.e6. PubMed ID: 27016702
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
Yu SS; Cai Y; Ye JT; Pi RB; Chen SR; Liu PQ; Shen XY; Ji Y
Br J Pharmacol; 2013 Jan; 168(1):117-28. PubMed ID: 22335191
[TBL] [Abstract][Full Text] [Related]
7. USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation.
Lin Z; Yang H; Tan C; Li J; Liu Z; Quan Q; Kong S; Ye J; Gao B; Fang D
Cell Rep; 2013 Dec; 5(6):1639-49. PubMed ID: 24332849
[TBL] [Abstract][Full Text] [Related]
8. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.
Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P
J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific peptidase 10 attenuates the ferroptosis to promote thyroid cancer malignancy by facilitating GPX4 via elevating SIRT6.
Lian F; Dong D; Pu J; Yang G; Yang J; Yang S; Wang Y; Zhao B; Lu M
Environ Toxicol; 2024 Mar; 39(3):1129-1139. PubMed ID: 37860888
[TBL] [Abstract][Full Text] [Related]
10. The nuclear sirtuin SIRT6 protects the heart from developing aging-associated myocyte senescence and cardiac hypertrophy.
Pillai VB; Samant S; Hund S; Gupta M; Gupta MP
Aging (Albany NY); 2021 May; 13(9):12334-12358. PubMed ID: 33934090
[TBL] [Abstract][Full Text] [Related]
11. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
[TBL] [Abstract][Full Text] [Related]
12. EGCG inhibits pressure overload-induced cardiac hypertrophy via the PSMB5/Nmnat2/SIRT6-dependent signalling pathways.
Cai Y; Yu SS; He Y; Bi XY; Gao S; Yan TD; Zheng GD; Chen TT; Ye JT; Liu PQ
Acta Physiol (Oxf); 2021 Apr; 231(4):e13602. PubMed ID: 33315278
[TBL] [Abstract][Full Text] [Related]
13. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ
Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
[TBL] [Abstract][Full Text] [Related]
15. HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling Pathway.
Goto J; Otaki Y; Watanabe T; Kobayashi Y; Aono T; Watanabe K; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Arimoto T; Takahashi H; Shishido T; Watanabe M
Hypertension; 2020 Dec; 76(6):1868-1878. PubMed ID: 33131309
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Tumor Domain-Containing 7B Attenuates Pathological Cardiac Hypertrophy by Inhibiting Ubiquitination and Degradation of Krüppel-Like Factor 4.
Du BB; Zhang JL; Kong LY; Shi HT; Zhang DH; Wang X; Yang CL; Li PC; Yao R; Liang C; Wu LM; Huang Z
J Am Heart Assoc; 2023 Dec; 12(24):e029745. PubMed ID: 38084712
[TBL] [Abstract][Full Text] [Related]
18. Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1.
Yang R; Song C; Chen J; Zhou L; Jiang X; Cao X; Sun Y; Zhang Q
Phytomedicine; 2020 Apr; 69():153211. PubMed ID: 32259676
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.
Yamamura S; Izumiya Y; Araki S; Nakamura T; Kimura Y; Hanatani S; Yamada T; Ishida T; Yamamoto M; Onoue Y; Arima Y; Yamamoto E; Sunagawa Y; Yoshizawa T; Nakagata N; Bober E; Braun T; Sakamoto K; Kaikita K; Morimoto T; Yamagata K; Tsujita K
Hypertension; 2020 Jan; 75(1):98-108. PubMed ID: 31735083
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
Puhl SL; Kazakov A; Müller A; Fries P; Wagner DR; Böhm M; Maack C; Devaux Y
Br J Pharmacol; 2016 Jan; 173(1):88-102. PubMed ID: 26406609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
